Average Co-Inventor Count = 8.67
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (14 from 2,405 patents)
2. Targegen, Inc. (7 from 13 patents)
3. Acurx Pharmaceuticals, LLC (3 from 4 patents)
4. Msd Italia S.r.l. (2 from 7 patents)
24 patents:
1. 11001592 - DNA polymerase IIIC inhibitors and use thereof
2. 10836772 - DNA polymerase IIIC inhibitors and use thereof
3. 10745377 - Piperidine or piperazine linked imidazole and triazole derivatives and methods of use
4. 10723741 - DNA polymerase IIIC inhibitors and use thereof
5. 9981969 - Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
6. 9573939 - Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
7. 9556202 - Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug
8. 9549921 - Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C
9. 9549917 - Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
10. 9504690 - Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases
11. 9364482 - Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
12. 9265773 - Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
13. 9242998 - Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
14. 9090661 - Inhibitors of hepatitis C virus replication
15. 8871759 - Inhibitors of hepatitis C virus replication